CORCEPT THERAPEUTICS INC (CORT)

Import this data to Google Sheets with:

=jivedata("CORT","financials")

Full statements spill as a table. For one cell: =jivedata("CORT","Revenue") or =jivedata("CORT","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

CORCEPT THERAPEUTICS INC

CORT • CIK 0001088856

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$482,375	$675,040	$761,407	$830,813
Operating Income (Loss)	$107,282	$136,951	$44,797	$6,405
Nonoperating Income (Expense)	$17,275	$24,542	$21,666	$19,964
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$124,557	$161,493	$66,463	$26,369
Income Tax Expense (Benefit)	$18,417	$20,284	$-33,189	$-28,813
Net Income (Loss) Attributable to Parent	$106,140	$141,209	$99,652	$55,182
Net Income (Loss) Available to Common Stockholders, Basic	$105,496	$139,733	$98,171	$54,270
Cost of Goods and Services Sold	$6,481	$10,882	$12,977	$14,085
Research and Development Expense	$184,353	$246,887	$254,908	$253,857
Selling, General and Administrative Expense	$184,259	$280,320	$448,725	$556,466
Costs and Expenses	$375,093	$538,089	$716,610	$824,408
Weighted Average Number of Shares Outstanding, Basic	103,560,000	103,232,000	103,862,000	104,663,000
Weighted Average Number of Shares Outstanding, Diluted	111,742,000	113,480,000	119,987,000	116,133,000

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$135,551	$127,665	$120,495	$111,039
Marketable Securities, Current	$232,670	$255,669	$251,657	$197,158
Inventory, Noncurrent	$8,244	$3,583	$11,094	$18,956
Accounts Receivable, after Allowance for Credit Loss, Current	$41,123	$53,976	$59,786	$76,920
Operating Lease, Right-of-Use Asset	$120	$5,324	$4,583	$6,860
Inventory, Net	$7,730	$12,412	$12,868	$13,185
Property, Plant and Equipment, Net	$195	$2,689	$1,890	$5,133
Prepaid Expense and Other Assets, Current	$27,562	$21,880	$40,658	$41,374
Marketable Securities, Noncurrent	$57,176	$219,831	$160,270	$236,451
Assets, Current	$458,636	$471,602	$485,464	$439,676
Other Assets, Noncurrent	$6,541	$6,610	$5,153	$2,946
Deferred Income Tax Assets, Net	$90,605	$130,914	$168,197	$178,680
Assets	$621,517	$840,553	$836,651	$888,702
Operating Lease, Liability, Noncurrent	—	$6,107	$5,023	$7,504
Accrued Income Taxes, Noncurrent	$10,307	$14,084	$15,176	$15,488
Liabilities	$114,812	$160,964	$188,846	$182,926
Accounts Payable, Current	$17,396	$15,376	$40,444	$14,910
Accrued Liabilities, Current	$51,628	$90,700	$90,603	$115,347
Operating Lease, Liability, Current	$151	$829	$1,084	$1,917
Liabilities, Current	$104,505	$140,773	$166,085	$153,802
Preferred Stock, Value, Issued	—	—	$0	$0
Common Stock, Value, Issued	—	—	$140	$142
Treasury Stock, Common, Value	$635,078	$696,173	$966,586	$998,013
Additional Paid in Capital, Common Stock	—	—	$968,600	$1,048,598
Accumulated Other Comprehensive Income (Loss), Net of Tax	$609	$-217	$2,264	$436
Retained Earnings (Accumulated Deficit)	$402,526	$543,735	$643,387	$654,613
Stockholders' Equity Attributable to Parent	$506,705	$679,589	$647,805	$705,776
Preferred Stock, Shares Authorized	10,000,000	10,000,000	10,000,000	10,000,000
Preferred Stock, Shares Outstanding	0	0	0	0
Common Stock, Shares Authorized	280,000,000	280,000,000	280,000,000	280,000,000
Common Stock, Shares, Issued	134,344,000	137,753,000	142,518,000	142,518,000
Common Stock, Shares, Outstanding	103,405,000	105,113,000	105,966,000	105,966,000
Treasury Stock, Common, Shares	30,938,000	32,640,000	36,552,000	36,552,000
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss	—	—	$511,695	$513,603
Prepaid Expense, Current	—	$9,492	$23,257	$17,568
Other Assets, Current	—	$6,078	$7,102	$8,363
Prepaid Taxes	—	—	$14,600	$4,462
Accrued Marketing Costs, Current	$1,771	$3,345	$10,610	$16,492
Other Accrued Liabilities, Current	$654	$2,272	$6,914	$14,753

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$106,140	$141,209	$99,652	$55,182
Net Cash Provided by (Used in) Operating Activities	$127,039	$198,067	$141,996	$109,700
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	—	—	$1,442	$-602
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$69,222	$-7,886	$-7,170	$8,294
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$135,551	$127,665	$120,495	$140,664
Share-based Payment Arrangement, Noncash Expense	$48,940	$61,354	$84,500	$96,106
Payments to Acquire Property, Plant, and Equipment	$139	$2,172	$211	$2,779
Accretion (Amortization) of Discounts and Premiums, Investments	$9,128	$10,938	$5,103	$5,103
Proceeds from Sale and Maturity of Marketable Securities	—	$412,878	$389,576	$303,352
Depreciation, Depletion and Amortization	$577	$795	$1,149	$2,039
Payments to Acquire Marketable Securities	$328,748	$588,310	$319,607	$322,471
Deferred Income Tax Expense (Benefit)	$-29,493	$-40,191	$-37,537	$-16,297
Net Cash Provided by (Used in) Investing Activities	$90,906	$-177,604	$69,758	$-21,898
Operating Lease, Right-of-Use Asset, Amortization Expense	$1,320	$541	$741	$741
Proceeds from Stock Options Exercised	—	—	$15,869	$14,635
Proceeds from Stock Plans	—	$5,459	$9,621	$10,831
Payments for Repurchase of Common Stock	—	$15,664	$172,915	$42,464
Payment, Tax Withholding, Share-based Payment Arrangement	$9,106	$22,301	$72,941	$61,908
Net Cash Provided by (Used in) Financing Activities	$-148,723	$-28,349	$-220,366	$-78,906
Income Taxes Paid, Net	$47,602	$60,267	$12,969	$12,969
Increase (Decrease) in Accounts Receivable	$10,066	$12,853	$5,810	$12,353
Increase (Decrease) in Insurance Settlements Receivable	—	—	$0	$0
Increase (Decrease) in Inventories	$-1,265	$-305	$7,481	$10,996
Increase (Decrease) in Prepaid Expense and Other Assets	$11,603	$-5,422	$18,917	$15,345
Increase (Decrease) in Other Operating Assets	$1,483	$69	$-1,457	$-1,457
Increase (Decrease) in Accounts Payable	$5,778	$-2,248	$25,068	$-8,966
Increase (Decrease) in Other Accrued Liabilities	$17,649	$38,242	$3,928	$28,860
Increase (Decrease) in Accrued Taxes Payable	$1,210	$3,777	$1,092	$1,092
IncreaseDecreaseInOperatingLeaseLiability	$-1,289	$183	$-829	$-829

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("CORT","financials")

Full statements spill as a table. For one cell: =jivedata("CORT","Revenue") or =jivedata("CORT","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.